Ovarian cancer is the leading cause of death from gynecologic cancer in the developed countries. It is usually diagnosed in advanced stage since it is often symptomless or symptoms are nonspecific in early course of the disease. It has a high recurrence rate and poor prognosis in advanced disease. Ovarian cancer has distinct type of disease spread in abdomen and above diaphragm. Surgery is irreplaceable in staging but multimodality imaging approach is often needed during the diagnosis, treatment monitoring, and follow-up of patients with ovarian cancer, typically ultrasound, CT, MRI and PET/CT are the main modalities used. The current clinical role of PET/CT in evaluation of ovarian cancer during staging, treatment prognostication and response assessment, and in disease recurrence is discussed in this review compared to conventional imaging.
PET/CT for Evaluation of Ovarian Cancer.
J. Kemppainen,J. Hynninen,J. Virtanen,M. Seppänen
Published 2019 in Seminars in nuclear medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Seminars in nuclear medicine
- Publication date
2019-07-04
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-87 of 87 references · Page 1 of 1
CITED BY
Showing 1-51 of 51 citing papers · Page 1 of 1